Anika Therapeutics Cash Flow Statement (2010-2026) | ANIK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	6.53M	0.56M	-10.75M	-2.93M	-2.84M	-4.16M	6.08M	-10.35M	-2.77M	-6.54M	17.10M	-2.56M	2.45M	-28.07M	-19.38M	-0.92M	0.68M	0.85M	-1.51M
Depreciation and Depletion (Quarter)												1.20M	1.20M	1.30M	1.20M	1.20M	1.30M	1.40M	1.40M	1.40M
Share-based Compensation (Quarter)	2.80M	2.86M	3.17M	2.54M	4.08M	3.88M	3.81M	3.72M	4.15M	3.56M	3.81M	3.25M	3.12M	3.39M	2.25M	2.86M	2.21M	-0.13M	2.59M	6.64M
Deferred Taxes (Quarter)	2.36M	-0.18M	-2.78M	-0.27M	-1.75M	-1.47M	-1.78M	-2.37M	-0.90M	-1.21M	-1.84M	0.19M	0.02M	-0.18M	0.23M	0.02M	-0.00M	0.00M	-0.03M	0.11M
Gains from Sales and Divestitures (Quarter)		0.09M	0.09M	0.09M	0.02M	0.02M	0.02M	0.18M	0.25M	0.26M		0.25M	0.30M	0.31M	0.31M	0.25M	0.32M		0.32M	0.31M
Gains from Investment Securities (Quarter)	0.00M	-3.45M	0.06M	0.03M	0.40M		-0.28M	0.06M	0.02M	1.10M	-0.01M	0.09M	0.00M	-0.00M	1.47M	0.09M	0.02M	0.00M	1.27M	0.10M
Asset Writedowns and Impairment (Quarter)	0.40M	1.30M	2.93M	0.03M	0.19M	0.22M	-0.45M	0.10M	0.14M		2.99M	2.06M	0.68M	3.10M	-25.88M	0.83M	3.01M	1.13M	-4.97M	0.11M
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)		4.65M	0.97M	0.01M	0.02M	0.08M	1.05M	0.63M	0.19M	0.01M	0.13M	0.32M	0.30M	0.25M			0.00M		0.00M	1.67M
Cash from Operations (Quarter)	4.29M	2.06M	4.47M	-1.87M	3.09M	2.71M	0.48M	-3.62M	-8.29M	6.49M	3.64M	-0.13M	-1.07M	5.02M	1.58M	-0.13M	-0.19M	6.87M	4.64M	-4.85M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
Amortizatization of Intangibles (Quarter)	3.52M	1.96M	1.95M	1.95M	-1.15M	5.04M	1.95M	0.54M	0.54M	0.55M	6.15M	0.33M	0.65M	0.59M	-0.32M	0.21M	0.86M	-0.71M	1.70M	0.46M
Amortization of Deferred Charges (Quarter)	0.51M	0.40M
Depreciation & Amortization (CF) (Quarter)	1.54M	1.62M	1.78M	1.67M	1.76M	1.55M	1.72M	1.60M	1.60M	1.60M	1.63M	1.73M	1.73M	1.86M	1.56M	1.38M	1.28M	1.39M	1.32M	1.41M
Change in Working Capital
Change in Receivables (Quarter)	2.87M	2.97M	-2.10M	-0.38M	3.49M	1.88M	0.65M	-4.06M	6.17M	-1.92M	1.10M	-3.62M	1.76M	-4.78M	3.27M	-3.03M	2.38M	-1.29M	1.54M	2.18M
Change in Inventory (Quarter)	2.76M	0.32M	-0.50M	0.60M	0.94M	2.39M	2.94M	3.06M	3.09M	2.10M	3.14M	4.09M	4.72M	3.00M	-2.39M	-0.52M	-1.73M	0.44M	1.78M	5.41M
Change in Account Payables (Quarter)	-0.83M	-0.06M	-0.40M	-0.47M	0.76M	0.25M	1.43M	-0.71M	-0.32M	-0.29M	1.31M	0.40M	0.15M	-2.93M	-0.12M	0.05M	-1.11M	0.23M	0.88M	0.74M
Change in Accured Expenses (Quarter)	3.56M	0.80M	0.41M	-2.93M	1.76M	1.28M	-0.56M	0.67M	-4.31M	4.56M	0.73M	-3.11M	-1.82M	2.20M	-0.94M	-3.09M	-2.16M	3.61M	0.14M	-1.34M
Change in Taxes (Quarter)	-0.24M	1.06M	-0.89M	-0.62M	1.28M	-0.23M	1.01M	0.68M	-0.40M	-0.18M	0.42M	0.09M	-0.76M	1.24M	0.10M	-0.01M	-0.43M	-0.02M	0.34M	1.19M
Other Working Capital Changes (Quarter)	-1.52M	-0.26M	0.44M	1.19M	-1.95M	-0.29M	1.85M	0.46M	-1.22M	-0.06M	0.26M	0.55M	-1.27M	0.22M	-0.05M	0.20M	-1.00M	-0.22M	-1.31M	1.73M
Investing Activities
Capital Expenditures (Quarter)	2.16M	-2.51M	-0.20M	1.33M	1.94M	1.69M	-4.85M	1.39M	-1.33M	3.53M	-2.77M	0.62M	4.59M	1.22M	-5.79M	0.50M	3.79M	-4.25M	0.63M	0.06M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)																	0.60M		-0.60M
Acquisitions (Quarter)	0.00M	0.01M	0.11M
Divestments (Quarter)																4.50M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-2.32M	-1.29M	-1.24M	-1.33M	-1.94M	-1.69M	-2.53M	-1.39M	-1.46M	-0.74M	-1.84M	-1.81M	-3.40M	-1.82M	-1.31M	1.67M	-0.54M	-1.73M	0.20M	-1.24M
Financing Activities
Other financing activities (Quarter)	0.64M	0.37M	-0.86M	0.01M	0.03M	0.07M	0.83M	0.01M	0.43M	0.11M	-0.52M	0.02M	0.21M	0.02M	2.35M	1.47M	0.08M	0.01M	0.00M	1.66M
Cash from Financing Activities (Quarter)	0.59M	-6.98M	0.06M	-0.86M	-0.05M	-4.61M	0.67M	-1.61M	-4.94M	-0.11M	0.34M	-2.27M	-1.11M	-3.99M	-5.35M	-5.44M	0.18M	-0.01M	-5.28M	-10.35M
Additional items
Exchange Rate Effect (Quarter)	0.01M	0.01M	0.12M	-0.00M	-0.04M	-0.02M	-0.07M	0.03M	0.03M	-0.05M	0.08M	-0.03M	-0.22M	0.34M	-0.13M	0.11M	0.34M	-0.30M	-0.07M	-0.03M
Change in Cash (Quarter)	2.58M	-6.21M	3.41M	-4.06M	1.07M	-3.62M	-1.45M	-6.59M	-14.67M	5.58M	2.22M	-4.24M	-5.81M	-0.45M	-5.21M	-3.79M	-0.20M	4.82M	-0.51M	-16.46M
Free Cash Flow (Quarter)	2.13M	4.57M	4.68M	-3.19M	1.15M	1.02M	5.33M	-5.01M	-6.96M	2.96M	6.41M	-0.75M	-5.66M	3.80M	7.37M	-0.63M	-3.98M	11.12M	4.01M	-4.90M
Net Cash Flow (Quarter)	2.57M	-6.21M	3.29M	-4.06M	1.10M	-3.59M	-1.38M	-6.62M	-14.69M	5.63M	2.14M	-4.21M	-5.58M	-0.79M	-5.08M	-3.90M	-0.55M	5.12M	-0.44M	-16.43M

Research Tools

Anika Therapeutics Cash Flow Statement (2010-2026) | ANIK

Create an account

Sign In

Reset Password